ticlopidine

DRUG5 trials

Sponsors

National Institute of Neurological Disorders and Stroke (NINDS), Sanofi, Turku University Hospital, Janssen Research & Development, LLC

Conditions

Cerebral InfarctionHealthyMyocardial InfarctionPeripheral Arterial Disease (PAD)PharmacodynamicsPharmacokineticsStable AnginaStroke

Phase 1

A Study to Assess the Effect of Ticlopidine on the Pharmacokinetics, Safety, and Tolerability of Intranasally Administered Esketamine in Healthy Participants

CompletedNCT03298906

Janssen Research & Development, LLCHealthy

Start: 2017-09-26End: 2017-11-27Updated: 2025-04-27

Phase 3

Safety Evaluation of Clopidogrel Sulfate in Patients With Stable Angina/Old Myocardial Infarction to Whom Percutaneous Coronary Intervention is Being Planned

CompletedNCT00821834

SanofiMyocardial Infarction, Stable Angina

Start: 2008-12-31End: 2010-08-31Updated: 2011-07-26

Safety Evaluation of Clopidogrel Sulfate in Patients With Peripheral Arterial Disease

CompletedNCT00862420

SanofiPeripheral Arterial Disease (PAD)

Start: 2009-02-28End: 2011-05-31Updated: 2012-07-17

Phase 4

Antiplatelet Therapy to Prevent Stroke in African Americans

CompletedNCT00004727

National Institute of Neurological Disorders and Stroke (NINDS)Cerebral Infarction, Stroke

Updated: 2005-06-24

Effect of Itraconazole and Ticlopidine on the Pharmacokinetics and Pharmacodynamics of Oral Tramadol

CompletedNCT01214941

Turku University HospitalPharmacodynamics, Pharmacokinetics

Start: 2010-09-30End: 2010-12-31Updated: 2011-04-13

Related Papers

Clopidogrel for Atherothrombotic Event Management in Patients with Peripheral Arterial Disease (COOPER) Study: Safety and Efficacy of Clopidogrel versus Ticlopidine in Japanese Patients.

2012-01-0110 citations